Search

Displaying results 6581 - 6590 of 10000 in total
  1. Drug

    Tuvatidine

    go.drugbank.com/drugs/DB21229
    Experimental

    Tuvatidine has a monoisotopic molecular weight of 391.07 Da. … Tuvatidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tuvatidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  2. Drug

    Octaverine

    go.drugbank.com/drugs/DB21449
    Experimental

    Octaverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Octaverine is a spasmolytic with a papaverine-like action. … Octaverine has a monoisotopic molecular weight of 397.19 Da.

  3. Drug

    Icanbelimod

    go.drugbank.com/drugs/DB21572
    Experimental

    Icanbelimod has a monoisotopic molecular weight of 409.18 Da. … Icanbelimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant.

  4. Drug

    Uplarafenib

    go.drugbank.com/drugs/DB21661
    Experimental

    Uplarafenib has a monoisotopic molecular weight of 494.12 Da. … Uplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  5. Drug

    Fosrolapitant

    go.drugbank.com/drugs/DB21723
    Investigational

    Fosrolapitant has a monoisotopic molecular weight of 654.16 Da. … Fosrolapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Fosrolapitant is a neurokinin NK1​ (substance P) receptor antagonist.

  6. Drug

    Flezurafenib

    go.drugbank.com/drugs/DB21725
    Experimental

    Flezurafenib has a monoisotopic molecular weight of 456.16 Da. … Flezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  7. Drug

    Enlicitide

    go.drugbank.com/drugs/DB22580
    ApprovedInvestigational

    Enlicitide is a macrocyclic peptide inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9). … (CORALreef Lipids), and by 59% in patients with HeFH (CORALreef HeFH), with comparable reductions in non-HDL-C and apolipoprotein B.

  8. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    Ledaborbactam etzadroxil has a monoisotopic molecular weight of 391.18 Da. … Ledaborbactam etzadroxil is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor.

  9. Drug

    CRA-028129

    go.drugbank.com/drugs/DB05951
    Experimental

    CRA-028129 is cathepsin S inhibitor which is under investigation for the treatment of psoriasis.

  10. Drug

    Danegaptide

    go.drugbank.com/drugs/DB11821
    Investigational

    Danegaptide has been investigated for the treatment of Focus of Study is STEMI.